Continuous combined hormone replacement therapy and its effects

Hospital Medicine

Volumn 60, Issue 8, 1999, Pages 584-587

  Sturdee, David W ^a  

^a SOLIHULL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR; CARDIOVASCULAR DISEASE; DRUG COMBINATION; DRUG EFFECT; ENDOMETRIUM; ESTROGEN THERAPY; FEMALE; HUMAN; PATIENT COMPLIANCE; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; RISK FACTOR;

BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; DRUG COMBINATIONS; ENDOMETRIUM; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT COMPLIANCE; RISK FACTORS;

EID: 0033169840     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.1999.60.8.1180     Document Type: Article

References (21)

1. Abdalla HI, Hart DM, Lindsay R, Leggate I, Hooke A (1985) Prevention of bone mineral loss in postmenopausal women by norethisterone. Obstet Gynecol 66: 789-92
2. Archer DF, Pickar JH, Bottiglioni F (1994) Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Obstet Gynecol 83: 686-92
3. Baerug U, Winge T, Nordland G et al (1998) Do continuations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms? Climacteric 1: 219-28
4. Christiansen C, Riis BJ (1990) 17 β-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women. J Clin Endocrinol Metab 71: 836-41
5. Comerci JT, Fields AL, Runowicz CD, Goldberg GL (1997) Continuous low-dose combined hormone replacement therapy and the risk of endometrial cancer. Gynecol Oncol 64:425-30
6. Daly E, Vessey MP, Hawkins MM et al (1996) Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 348: 977-80
7. Dören M, Reuther C, Minne HW, Schneider HPG (1995) Superior compliance and efficacy of continuous combined oral estrogen/progestogen replacement therapy in postmenopausal women. Am J Obstet Gynecol 173: 1446-51
8. Hammar M, Christau S, Nathorst-Bôôs J, Rud T, Garre K (1998) A double blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. Br J Obstet Gynaecol 105: 904-11
9. Hirvonen E, Mälkönen M, Manninen V (1981) Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N EngI J Med 304: 560-3
10. Hulley S, Grady D, Bush T et al (1998) randomised trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605-12
11. Leather AT, Savvas M. Studd JWW (1991) Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women. Obstet Gynecol 78: 1008-10
12. Magos A, Brincat M, Studd JWW. Wardle P, Schlesinger P, O'Dowd T (1985) Amenorrhoea and endometrial atrophy with continuous oral estrogens and progestin therapy in post-menopausal women. Obstet Gynecol 65: 496-9
13. Mattsson LÅ, Cullberg G. Samsioe G (1982) Evaluation of a continuous combined oestrogen/progestogen regimen for climacteric complaints. Maturilas 4: 95-102
14. Moore RA (1999) Livial: a review of clinical studies. Br J Obestet Gynaecol 106(Suppl 19): 1-21
15. Ryan PJ, Harrison R, Blake GM, Fogelman I (1992) Compliance with hormone replacement therapy (HRT) after screening for postmenopausal osteoporosis. Br J Obstet Gvnaecol 99: 325-8
16. Speroff L, Rowan J, Symons J, Genaut H, Wilborn W (1996) The comparative effect on bone density, endometrium and lipids of continuous hormones as replacement therapy (CHART study): a randomised controlled trial. JAMA 276: 1397-403
17. The Writing Group for the PEPI trial (1995) Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 273: 199-208
18. UdofTL, Langenberg P, Adaski EY (1995) Combined continuous hormone replacement therapy: a critical review. Obstet Gynecol 86: 306-16
19. Wells M (1996) Endometrial response to continuous combined HRT. Abstract 539 at 8th International Congress on the menopause, Sydney
20. Whitehead MI, Townsend PT, Pryse-Davies J, Ryder TA, King RJB (1981) Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N EnglJ Med 305: 1599-605
21. Woodruff JD, Pickar JH (1994) Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. Am J Obstet Gvnecol 170: 1213-23